Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.

Regeneron Pharmaceuticals and a privacy ombudsman are raising concerns over a push by 23andMe’s co-founder to challenge the ...

Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...

On 23 March 2025, the direct-to-consumer genetic testing company 23andMe filed a voluntary Chapter 11 petition in a US bankruptcy court.1 The objective of this bankruptcy is to sell the company ...

You've still got about a month and a half to claim your share of 23andMe's $30 million settlement. Genetic testing company 23andMe was struck by a prolonged data breach that allowed hackers to gain ...

Genetic testing company 23andMe had 15 million consumers who turned to them to learn more about their ancestry and understand their disposition to diseases.

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of a law professor. In a report due before June 10, he’ll recommend to the ...

This guide was reviewed by a Business News Daily editor to ensure it provides comprehensive and accurate information to aid your buying decision. As technologies that capture and analyze data ...